Effects of lofexidine on stress-induced and cue-induced opioid craving and opioid abstinence rates: preliminary findings
Authors:
- 29 November 2006
- journal article
- research article
- Published by Springer Nature in Psychopharmacology
- Vol. 190 (4) , 569-574
Abstract
A preliminary study examined whether lofexidine decreases stress-induced and cue-induced opioid craving and improves opioid abstinence in naltrexone-treated opioid-dependent individuals. Eighteen opioid-dependent patients were stabilized for 4 weeks with naltrexone (50 mg daily) and lofexidine (2.4 mg bid) before entering a 4-week randomized, double-blind placebo-controlled discontinuation study where one group continued on lofexidine for an additional 4 weeks, while the second was tapered to placebo (Lofexidine–naltrexone vs Placebo–naltrexone). Ten patients also participated in guided imagery exposure to stress, drug cue, and neutral scenarios in a single laboratory session. Lofexidine–naltrexone patients had higher opioid abstinence rates and improved relapse outcomes as compared to the Placebo–naltrexone group. Furthermore, Lofexidine–naltrexone patients had significantly lower heart rates and an attenuated stress and drug cue-induced opioid craving response in the laboratory as compared to the Placebo–naltrexone group. Although preliminary, these findings are the first to document lofexidine’s potential in addressing stress-related opioid craving and relapse outcomes in humans. The results also suggest that combination therapies that target both drug-related reinforcement (naltrexone) and stress- and cue-related aspects of drug seeking could be beneficial in addiction relapse prevention. Further development of lofexidine to address stress-related opioid craving and relapse is warranted.Keywords
This publication has 21 references indexed in Scilit:
- Neurobiology of craving, conditioned reward and relapseCurrent Opinion in Pharmacology, 2005
- The reinstatement model of drug relapse: history, methodology and major findingsPsychopharmacology, 2002
- Office-Based Treatment of Opioid-Dependent PatientsNew England Journal of Medicine, 2002
- Repeated Lofexidine Treatment Attenuates Stress-Induced, But not Drug Cues-Induced Reinstatement of a Heroin-Cocaine Mixture (Speedball) Seeking in RatsNeuropsychopharmacology, 2001
- Conditioning factors in drug abuse: can they explain compulsion?Journal of Psychopharmacology, 1998
- Clinical Medications Development for Opiate Addiction: Focus on Nonopioids and Opioid Antagonists for the Amelioration of Opiate Withdrawal Symptoms and Relapse PreventionSeminars in Neuroscience, 1997
- Effects of opioid and dopamine receptor antagonists on relapse induced by stress and re-exposure to heroin in ratsPsychopharmacology, 1996
- Stress reinstates heroin-seeking in drug-free animals: An effect mimicking heroin, not withdrawalPsychopharmacology, 1995
- Modulation of opiate responses in brain noradrenergic neurons by the cyclic AMP cascade: Changes with chronic morphineNeuroscience, 1993
- Effectiveness of lofexidine in blocking morphine-withdrawal signs in the ratPharmacology Biochemistry and Behavior, 1980